Dexamethasone reduces the risk of bortezomib-induced pulmonary complications in Japanese myeloma patients.
Shimazaki
Chihiro
C
Kobayashi
Yutaka
Y
Inaba
Tohru
T
Taniwaki
Masafumi
M
D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D044466:Asian People; D001897:Boronic Acids / Q000008:administration & dosage / Q000009:adverse effects*; D000069286:Bortezomib; D003907:Dexamethasone / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007564:Japan; D008171:Lung Diseases / Q000209:etiology / Q000517:prevention & control*; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications / Q000628:therapy; D011480:Protease Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D011719:Pyrazines / Q000008:administration & dosage / Q000009:adverse effects*; D033581:Stem Cell Transplantation / Q000009:adverse effects; D014184:Transplantation, Homologous
D000893:Anti-Inflammatory Agents; D001897:Boronic Acids; D011480:Protease Inhibitors; D011719:Pyrazines; D000069286:Bortezomib; D003907:Dexamethasone